期刊文献+

乳腺导管内癌手术方式的选择 被引量:2

下载PDF
导出
摘要 乳腺导管内癌(DCIS)是一种癌前病变,一方面有发展成为浸润癌的风险,另一方面病变局限于导管内,未发生浸润和远处转移。因其自然病程、生物学行为多样,加之患者的个体情况复杂,没有一种术式适合所有的DCIS患者,但DICS的共性是预后良好,大部分患者通过治疗可以达到治愈的目的。因此,DCIS治疗的根本是提高治愈率,手术原则是保证局部控制不再复发。对于病理类型为粉刺型、病灶呈多灶性或多中心性生长、伴有微浸润、广泛局部切除难以保证阴性切缘等情况,保留乳房手术治疗会有较高的局部复发风险,对存在这些高危因素的患者应该选择全乳房切除术。
出处 《中国现代普通外科进展》 CAS 2011年第3期212-215,共4页 Chinese Journal of Current Advances in General Surgery
基金 山东省自然科学基金资助项目(Q2008C08)
  • 相关文献

参考文献45

二级参考文献103

共引文献55

同被引文献18

  • 1Cuzick J, Sestak I,Pinder S E, et al. Effect of tamoxifen and radio-therapy in women with locally excised ductal carcinoma in situ:long-term results from the UK/ANZ DCIS trial [J], Lancet Oncol,2011, 12(1):21-29.
  • 2Wang SY, Shamliyan T, Virnig BA, et al. Tumor characteristics aspredictors of local recurrence after treatment of ductal carcinoma insitu: a meta-analysis[J]. Breast Cancer Res Treat, 2011,127(1 ):1-14.
  • 3Vandenbussche CJ, Khouri N, Sbaity E, et al. Borderline atypicalductal hyperplasia/low -grade ductal carcinoma in situ on breastneedle core biopsy should be managed conservatively [J]. Am J SurgPathol, 2013,37(6):913.
  • 4Yi M, Meric-Bemstam F, Kuerer H M, et al. Evaluation of a breastcancer nomogram for predicting risk of ipsilateral breast tumor re-currences in patients with ductal carcinoma in situ after local exci-sion [J]. J Clin Oncol, 2012,30 {6) :600-607.
  • 5Solin L J, Gray R, Baehner FL, et al. A multigene expression assayto predict local recurrence risk for ductal carcinoma in situ of thebreast[J]. J Natl Cancer Inst, 2013,105 (10):701-710.
  • 6Brennan M E, Turner R M, Ciatto S, et al. Ductal carcinoma in situ atcore-needJe biopsy: meta-analysis of underestimation and predictorsof invasive breast cancer[J]. Radiology, 2011, 260(1 ):119-128.
  • 7Yu KD, Wu LM, Liu GY, et al. Different distribution of breast can-cer subtypes in breast ductal carcinoma in situ (DCIS), DCIS withmicroinvasion, and DCIS with invasion component[J]. Ann Surg On-col, 2011,18(5):1342-1348.
  • 8Partridge AH, Elmore JG, Saslow D, et al. Challenges in ductalcarcinoma in situ risk communication and decision-making: reportfrom an American Cancer Society and National Cancer Instituteworkshop[J]. CA Cancer J Clin, 2012,62(3): 203-210.
  • 9Luo J, Cochrane BB, Wactawski -Wende J, et al. Effects ofmenopausal hormone therapy on ductal carcinoma in situ of thebreast [J]. Breast Cancer Res Treat, 2013,137 (3):915-925.
  • 10De Morgan SE, Butow PN, Lobb EA, et al. Development and pilottesting of a communication aid to assist clinicians to communicatewith women diagnosed with ductal carcinoma in situ (DCIS) [J].Support Care Cancer, 2011,19(5):717-723.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部